Similar Articles
1051 Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinoma
1052 Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma
1053 Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients
1054 Liver transplantation as a management of hepatocellular carcinoma
1055 Chemokines and their receptors play important roles in the development of hepatocellular carcinoma
1056 Current systemic treatment of hepatocellular carcinoma: A review of the literature
1057 Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease
1058 Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives
1059 Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis
1060 Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA